Itolizumab-induced Modulation of Cell Surface CD6 is a Pharmacodynamic Marker of Drug Activity in SLE Patients <span>Dalena Chu, et. al.</span><span>American College of Rheumatology</span><span>2021</span>

11/02/2021

Download this Press Release PDF Format (opens in new window)

Dalena Chu, et. al.
Conference: American College of Rheumatology
Year: 2021